Literature DB >> 23026979

Neuroprotection and repair in multiple sclerosis.

Robin J M Franklin1, Charles ffrench-Constant, Julia M Edgar, Kenneth J Smith.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease that is considered by many people to have an autoimmune aetiology. In recent years, new data emerging from histopathology, imaging and other studies have expanded our understanding of the disease and may change the way in which it is treated. Conceptual shifts have included: first, an appreciation of the extent to which the neuron and its axon are affected in MS, and second, elucidation of how the neurobiology of axon-glial and, particularly, axon-myelin interaction may influence disease progression. In this article, we review advances in both areas, focusing on the molecular mechanisms underlying axonal loss in acute inflammation and in chronic demyelination, and discussing how the restoration of myelin sheaths via the regenerative process of remyelination might prevent axon degeneration. An understanding of these processes could lead to better strategies for the prevention and treatment of axonal loss, which will ultimately benefit patients with MS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23026979     DOI: 10.1038/nrneurol.2012.200

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  126 in total

1.  Evolution of clinical and molecular responses to bexarotene treatment in cutaneous T-cell lymphoma.

Authors:  F Ballanger; J M Nguyen; A Khammari; B Dréno
Journal:  Dermatology       Date:  2010-05-13       Impact factor: 5.366

2.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Authors:  Christina Marik; Paul A Felts; Jan Bauer; Hans Lassmann; Kenneth J Smith
Journal:  Brain       Date:  2007-11       Impact factor: 13.501

3.  Newly lesioned tissue in multiple sclerosis--a role for oxidative damage?

Authors:  Kenneth J Smith
Journal:  Brain       Date:  2011-06-15       Impact factor: 13.501

4.  Assembly and maintenance of nodes of ranvier rely on distinct sources of proteins and targeting mechanisms.

Authors:  Yanqing Zhang; Yoko Bekku; Yulia Dzhashiashvili; Stephen Armenti; Xiaosong Meng; Yo Sasaki; Jeffrey Milbrandt; James L Salzer
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

Review 5.  Hypoxia. 2. Hypoxia regulates cellular metabolism.

Authors:  William W Wheaton; Navdeep S Chandel
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

6.  Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.

Authors:  I Coman; M S Aigrot; D Seilhean; R Reynolds; J A Girault; B Zalc; C Lubetzki
Journal:  Brain       Date:  2006-06-09       Impact factor: 13.501

7.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

8.  Microtubule-associated protein 1B: a neuronal binding partner for myelin-associated glycoprotein.

Authors:  R Franzen; S L Tanner; S M Dashiell; C A Rottkamp; J A Hammer; R H Quarles
Journal:  J Cell Biol       Date:  2001-12-03       Impact factor: 10.539

9.  Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.

Authors:  Mark R Kotter; Wen-Wu Li; Chao Zhao; Robin J M Franklin
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

10.  Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.

Authors:  Raju Kapoor; Meirion Davies; Paul A Blaker; Susan M Hall; Kenneth J Smith
Journal:  Ann Neurol       Date:  2003-02       Impact factor: 10.422

View more
  107 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

Review 2.  Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.

Authors:  Ranjan Dutta
Journal:  Mult Scler       Date:  2013-09       Impact factor: 6.312

3.  Impact of prenatal immune challenge on the demyelination injury during adulthood.

Authors:  Abdeslam Mouihate; Hessah Al-Hashash; Sarah Rakhshani-Moghadam; Samah Kalakh
Journal:  CNS Neurosci Ther       Date:  2017-07-17       Impact factor: 5.243

4.  A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.

Authors:  Bentley J Hanish; Jennifer F Hackney Price; Ichiro Kaneko; Ning Ma; Arjan van der Vaart; Carl E Wagner; Peter W Jurutka; Pamela A Marshall
Journal:  Steroids       Date:  2018-04-26       Impact factor: 2.668

Review 5.  Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.

Authors:  Benjamin L L Clayton; Brian Popko
Journal:  Brain Res       Date:  2016-04-04       Impact factor: 3.252

6.  Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors.

Authors:  Marc Ehrlich; Sabah Mozafari; Michael Glatza; Laura Starost; Sergiy Velychko; Anna-Lena Hallmann; Qiao-Ling Cui; Axel Schambach; Kee-Pyo Kim; Corinne Bachelin; Antoine Marteyn; Gunnar Hargus; Radia Marie Johnson; Jack Antel; Jared Sterneckert; Holm Zaehres; Hans R Schöler; Anne Baron-Van Evercooren; Tanja Kuhlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-28       Impact factor: 11.205

7.  Ion channels boost axonal injury in multiple sclerosis.

Authors:  Reinhard Hohlfeld
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

Review 8.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 9.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

10.  Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.

Authors:  Martine El-Etr; Marion Rame; Celine Boucher; Abdel M Ghoumari; Narender Kumar; Philippe Liere; Antoine Pianos; Michael Schumacher; Regine Sitruk-Ware
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.